Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

Experimental Alopecia Pill Shows Promise

If results of a new Phase 3 study are successful, Concert Pharmaceuticals will likely submit the drug for FDA approval next year.

Concert Pharmaceutical
Concert Pharmaceuticals

If this year’s Oscars did anything, it put the severe form of hair loss known as alopecia in the limelight. The disease causes the body’s immune system to attack hair follicles, resulting in patchy hair loss, or in some cases total hair loss. Currently, there are no approved treatments for the disease. But according to a recent Boston Globe article, those afflicted with the condition have new hope in the form of a pill. An experimental treatment from Concert Pharmaceuticals has restored a near full head of hair in roughly 30-40% of people with alopecia.

Break out of the ordinary: see what’s new in life sciences packaging
<strong>At PACK EXPO Las Vegas, you’ll see machinery in action and new tech from 2,300 suppliers, collaborate with experts and explore transformative solutions. Join us in September to experience a breakthrough for life sciences products.</strong>
REGISTER NOW & SAVE!
Break out of the ordinary: see what’s new in life sciences packaging
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?